Growth Hormone Antagonist Therapies for Neurological Disorders and Veterinary Applications

This inventive concept leverages the core technology of the original patent to develop novel therapies for neurological disorders, veterinary applications, and age-related diseases, expanding the scope of growth hormone antagonist treatments beyond cancer.

The original patent disclosed a composition for treating cancer and other diseases using a human growth hormone receptor antagonist. However, there remains a need for effective treatments for neurological disorders, veterinary applications, and age-related diseases. This inventive concept addresses these limitations by exploring new applications and use cases for the core technology.

The new claims describe methods and systems for treating neurological disorders, delivering growth hormone receptor antagonists to target sites, and preventing or treating age-related diseases. These innovative approaches involve conjugating the antagonist with polyethylene glycol molecules, using microneedle arrays for transdermal delivery, and modifying the antagonist for increased efficacy against canine or feline cancers.

The new claims introduce novel and non-obvious applications of the growth hormone receptor antagonist technology, expanding its scope beyond cancer treatment and into new therapeutic areas. The inventive step lies in the identification of new uses and modifications that enable the antagonist to address unmet needs in neurological disorders, veterinary applications, and age-related diseases.

Alternative embodiments of the inventive concept could include using different polyethylene glycol molecules, modifying the antagonist for use in other diseases or conditions, or developing new formulations for oral or injectable delivery. Variations of the microneedle array design could also be explored to optimize transdermal delivery.

The inventive concept has significant commercial potential in the pharmaceutical and biotechnology industries, particularly in the areas of neurological disorders, veterinary medicine, and age-related diseases. The market for these applications is substantial, with a growing need for effective treatments and therapies.